During the past decade, Falun Hospital conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 3 clinical trials were completed, i.e. on average, 21.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Falun Hospital" #1 sponsor was "Karolinska Institutet" with 6 trials, followed by "Uppsala University" with 4 trials sponsored, "Fresenius Medical Care Deutschland GmbH" with 2 trials sponsored, "AO Clinical Investigation and Publishing Documentation" with 1 trials sponsored and "Anders Svenningsson" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Falun Hospital" #1 collaborator was "The Swedish Research Council" with 4 trials as a collaborator, "Uppsala University Hospital" with 2 trials as a collaborator, "Capio S:t Görans Hospital" with 1 trials as a collaborator, "Central European Myeloma Study Group" with 1 trials as a collaborator and "DSMM (Deutsche Studiengruppe Multiples Myelom)" with 1 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Falun Hospital" are "Acute Heart Failure" (2 trials), "Multiple Myeloma" (2 trials), "Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Myocardial Infarction" (2 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Falun Hospital" in a lesser frequency.

Most popular intervention types in "Falun Hospital" are "Drug" (10 trials), "Other" (4 trials), "Device" (3 trials), "Procedure" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (3 trials), "Placebo" (2 trials), "1 or 2 cycle(s) HDM (High Dose Melphalan)" (1 trials), "2 cycles of Bortezomib, Lenalidomide, Dexamethasone (VRD)" (1 trials) and "Acetylsalicylic acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Falun Hospital" are 21 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Falun Hospital". undefined are not yet recruiting, 6 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Falun Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Falun Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".